USD 0.01
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | -437.12 Thousand | -1.65 Million | -683.92 Thousand | -135.93 Thousand | -147.62 Thousand | -388.88 Thousand |
Net Income | -96.65 Thousand | -1.62 Million | 3.27 Million | -202.1 Thousand | -227.75 Thousand | -462.46 Thousand |
Depreciation & Amortization | - | - | - | 35.07 | - | - |
Deferred income taxes | - | - | - | -35.07 | - | - |
Stock-based compensation | 49.05 Thousand | 153.79 Thousand | 86.87 Thousand | 11.7 Thousand | 46.42 Thousand | 160.17 Thousand |
Change in working capital | -60.07 Thousand | 31.27 Thousand | -9194.00 | 16.78 Thousand | 27.88 Thousand | -76.36 Thousand |
Other non-cash items | -259.41 Thousand | -217.43 Thousand | -4.03 Million | 37.67 Thousand | 5826.00 | -10.23 Thousand |
Investing Cash Flow | 589.97 Thousand | -63.31 Thousand | 3.4 Million | -25 Thousand | -256.52 Thousand | -2.4 Million |
Investments in PPE | -125 Thousand | -63.31 Thousand | -36.58 Thousand | -25 Thousand | -454.43 Thousand | -2.36 Million |
Acquisitions | - | - | 3.31 Million | - | - | - |
Investment purchases | - | - | - | - | - | -40 Thousand |
Sales/Maturities of investments | 714.97 Thousand | - | - | - | - | - |
Other Investing Activities | 714.97 | - | 120.63 Thousand | - | 197.91 Thousand | -40 Thousand |
Financing Cash Flow | - | 17.5 Thousand | 176.13 Thousand | - | 237.67 Thousand | -96.29 |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | 17.5 Thousand | 200 Thousand | - | 275 Thousand | -96.28 Thousand |
Other Financing Activities | - | 17.50 | -23.86 Thousand | - | -37.32 Thousand | -96.29 |
Accounts receivables | -20.98 Thousand | 24.11 Thousand | -35.62 Thousand | 887.00 | 37.83 Thousand | -26.72 Thousand |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | -39.09 Thousand | 7156.00 | 26.42 Thousand | 15.9 Thousand | -9951.00 | -49.64 Thousand |
Cash at beginning of period | 1.46 Million | 3.16 Million | 270.21 Thousand | 431.14 Thousand | 597.62 Thousand | 3.48 Million |
Cash at end of period | 1.61 Million | 1.46 Million | 3.16 Million | 270.21 Thousand | 431.14 Thousand | 597.62 Thousand |
Capital Expenditure | -125 Thousand | -63.31 Thousand | -36.58 Thousand | -25 Thousand | -454.43 Thousand | -2.36 Million |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | 152.85 Thousand | -1.7 Million | 2.89 Million | -160.93 Thousand | -166.47 Thousand | -2.88 Million |
Free Cash Flow | -562.12 Thousand | -1.71 Million | -720.5 Thousand | -160.93 Thousand | -602.05 Thousand | -2.74 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -123.15 Thousand | -230.36 Thousand | 417.72 Thousand | -96.65 Thousand | -563.25 Thousand | 952.53 Thousand |
Depreciation & Amortization | - | - | - | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | 38.08 Thousand | 1954.00 | 1997.00 | 49.05 Thousand | 1997.00 | 39.3 Thousand |
Change in working capital | 59.76 Thousand | -8452.00 | -240.38 Thousand | -60.07 Thousand | 235.69 Thousand | -19.31 Thousand |
Other non-cash items | -31.2 Thousand | 161.5 Thousand | -66.2 Thousand | -259.41 Thousand | 26.84 Thousand | -1.1 Million |
Investing Cash Flow | 93.93 Thousand | - | - | 589.97 Thousand | 494.55 Thousand | 204.16 Thousand |
Investments in PPE | - | - | - | -125 Thousand | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | -12.7 Thousand | - | - | - | - | - |
Sales/Maturities of investments | 106.63 Thousand | - | - | 714.97 Thousand | 494.55 Thousand | 204.16 Thousand |
Other Investing Activities | 93.93 | - | - | 714.97 | 494.55 | 204.17 |
Financing Cash Flow | - | - | - | - | - | - |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | - | - | - | - |
Accounts receivables | 14 Thousand | -11.61 Thousand | 5094.00 | -20.98 Thousand | -28.19 Thousand | 1558.00 |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | 45.75 Thousand | 3158.00 | -245.48 Thousand | -39.09 Thousand | 263.88 Thousand | -20.87 Thousand |
Cash at beginning of period | 1.52 Million | 1.61 Million | 1.5 Million | 1.46 Million | 1.3 Million | 1.23 Million |
Cash at end of period | 1.54 Million | 1.52 Million | 1.61 Million | 1.61 Million | 1.5 Million | 1.3 Million |
Capital Expenditure | - | - | - | -125 Thousand | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | 13.33 Thousand | -88.91 Thousand | 116.21 Thousand | 152.85 Thousand | 195.82 Thousand | 74.89 Thousand |
Free Cash Flow | -80.59 Thousand | -88.91 Thousand | 116.21 Thousand | -562.12 Thousand | -298.72 Thousand | -129.26 Thousand |
NGKIF
HCL-INSYS
IGPL
TDVXF
OKTA
MAXHEALTH